Cargando…
Pembrolizumab-associated tumor development in a patient with Sézary syndrome
Autores principales: | Malachowski, Stephen J., Hatch, Leigh A., Sokol, Lubomir, Messina, Jane, Seminario-Vidal, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938917/ https://www.ncbi.nlm.nih.gov/pubmed/31909130 http://dx.doi.org/10.1016/j.jdcr.2019.11.005 |
Ejemplares similares
-
T-cell prolymphocytic leukemia presenting with erythematous patches, plaques, and erythema gyratum–like lesions masquerading as Sézary syndrome
por: Cohen, Leah, et al.
Publicado: (2019) -
Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome
por: Zhang, Yumeng, et al.
Publicado: (2020) -
Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018) -
Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023) -
New Insights Into the Complex Mutational Landscape of Sézary Syndrome
por: Mirza, Abu-Sayeef, et al.
Publicado: (2020)